Unknown

Dataset Information

0

Two Novel Pathogenic FBN1 Variations and Their Phenotypic Relationship of Marfan Syndrome.

ABSTRACT: Marfan syndrome is an autosomal dominant disease affecting connective tissue involving the ocular, skeletal systems with a prevalence of 1/5,000 to 1/10,000 cases. Especially cardiovascular system disorders (aortic root dilatation and enlargement of the pulmonary artery) may be life-threatening. We report here the genetic analysis results of three unrelated cases clinically diagnosed as Marfan syndrome. Deoxyribonucleic acid (DNA) was isolated from EDTA (ethylenediaminetetraacetic acid)-blood samples of the patients. A next-generation sequencing panel containing 15 genes including FBN1 was used to determine the underlying pathogenic variants of Marfan syndrome. Three different variations, NM_000138.4( FBN1 ):c.229G?>?A(p.Gly77Arg), NM_000138.4( FBN1 ):c.165-2A?>?G (novel), NM_000138.4( FBN1 ):c.399delC (p.Cys134ValfsTer8) (novel) were determined in our three cases referred with a prediagnosis of Marfan syndrome. Our study has confirmed the utility of molecular testing in Marfan syndrome to support clinical diagnosis. With an accurate diagnosis and genetic counseling for prognosis of patients and family testing, the prenatal diagnosis will be possible.

SUBMITTER: Yalcintepe S 

PROVIDER: S-EPMC7490121 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Two Novel Pathogenic <i>FBN1</i> Variations and Their Phenotypic Relationship of Marfan Syndrome.

Yalcintepe Sinem S   Demir Selma S   Atli Emine Ikbal EI   Deveci Murat M   Atli Engin E   Gurkan Hakan H  

Global medical genetics 20200820 2

Marfan syndrome is an autosomal dominant disease affecting connective tissue involving the ocular, skeletal systems with a prevalence of 1/5,000 to 1/10,000 cases. Especially cardiovascular system disorders (aortic root dilatation and enlargement of the pulmonary artery) may be life-threatening. We report here the genetic analysis results of three unrelated cases clinically diagnosed as Marfan syndrome. Deoxyribonucleic acid (DNA) was isolated from EDTA (ethylenediaminetetraacetic acid)-blood sa  ...[more]

Similar Datasets

Unknown Identification of a novel pathogenic variant in FBN1 associated with Marfan Syndrome.
| S-EPMC9235843 | biostudies-literature
Unknown Two novel mutations of FBN1 in Jordanian patients with Marfan syndrome.
| S-EPMC4694396 | biostudies-literature
Unknown Novel and recurrent <i>FBN1</i> mutations causing Marfan syndrome in two Chinese families.
| S-EPMC9792469 | biostudies-literature
Unknown Characterisation of four novel fibrillin-1 (FBN1) mutations in Marfan syndrome.
| S-EPMC1050701 | biostudies-other
Unknown Identification of Novel Causal FBN1 Mutations in Pedigrees of Marfan Syndrome.
| S-EPMC5932419 | biostudies-literature
Unknown Undescribed mutations in FBN1 gene in two family cases of Marfan syndrome.
| S-EPMC6279638 | biostudies-literature
Unknown Next-generation sequencing identifies novel mutations in the FBN1 gene for two Chinese families with Marfan syndrome.
| S-EPMC4918605 | biostudies-literature
Unknown Correction of the Marfan Syndrome Pathogenic FBN1 Mutation by Base Editing in Human Cells and Heterozygous Embryos.
| S-EPMC6224777 | biostudies-literature
Unknown A Novel Heterozygous Intronic FBN1 Variant Contributes to Aberrant RNA Splicing in Marfan Syndrome.
| S-EPMC11366968 | biostudies-literature
Unknown Identification of a novel FBN1 gene mutation in a Chinese family with Marfan syndrome.
| S-EPMC3185025 | biostudies-literature